"Photopheresis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A process in which peripheral blood is exposed in an extracorporeal flow system to photoactivated 8-methoxypsoralen (METHOXSALEN) and ultraviolet light - a procedure known as PUVA THERAPY. Photopheresis is at present a standard therapy for advanced cutaneous T-cell lymphoma; it shows promise in the treatment of autoimmune diseases.
| Descriptor ID |
D017893
|
| MeSH Number(s) |
E02.774.945.500.500 E04.292.762
|
| Concept/Terms |
Photopheresis- Photopheresis
- Extracorporeal Photopheresis
- Photopheresis, Extracorporeal
- Extracorporeal Photochemotherapy
- Extracorporeal Photochemotherapies
- Photochemotherapies, Extracorporeal
- Photochemotherapy, Extracorporeal
|
Below are MeSH descriptors whose meaning is more general than "Photopheresis".
Below are MeSH descriptors whose meaning is more specific than "Photopheresis".
This graph shows the total number of publications written about "Photopheresis" by people in this website by year, and whether "Photopheresis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Photopheresis" by people in Profiles.
-
A Prospective, Multicenter Study of Closed-System Extracorporeal Photopheresis for Children with Steroid-Refractory Acute Graft-versus-Host Disease. Transplant Cell Ther. 2022 05; 28(5):261.e1-261.e7.
-
Monitoring malignant T-cell clones by direct TCR expression assay in patients with leukemic cutaneous T-cell lymphoma during extracorporeal photopheresis. Photodermatol Photoimmunol Photomed. 2022 Mar; 38(2):158-168.
-
Randomized phase II trial of extracorporeal phototherapy and steroids vs. steroids alone for newly diagnosed acute GVHD. Bone Marrow Transplant. 2021 06; 56(6):1316-1324.
-
Anaphylaxis following administration of extracorporeal photopheresis for cutaneous T cell lymphoma. Dermatol Online J. 2020 Sep 15; 26(9).
-
United States Cutaneous Lymphoma Consortium recommendations for treatment of cutaneous lymphomas during the COVID-19 pandemic. J Am Acad Dermatol. 2020 Aug; 83(2):703-704.
-
CD209+ monocyte-derived myeloid dendritic cells were increased in patients with leukemic cutaneous T-cell lymphoma undergoing extracorporeal photopheresis via the CELLEXTM system. Photodermatol Photoimmunol Photomed. 2020 Jul; 36(4):290-298.
-
A phase II/III randomized, multicenter trial of prednisone/sirolimus versus prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-versus-host disease: BMT CTN 0801. Haematologica. 2018 11; 103(11):1915-1924.
-
Early initiation of extracorporeal photochemotherapy increases response for chronic graft versus host disease following steroid failure. Transfus Clin Biol. 2019 Feb; 26(1):32-37.
-
Extracorporeal photochemotherapy in mycosis fungoides. Transfus Clin Biol. 2017 Nov; 24(4):454-457.
-
An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease. Blood. 2017 07 20; 130(3):360-367.